Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis
Zhang X, Yang L, Szeto P, Abali GK, Zhang Y, Kulkarni A, Amarasinghe K, Li J, Vergara IA, Molania R, Papenfuss AT, McLean C, Shackleton M, Harvey KF
(2020), Oncogene, 39(30), 5267-81
Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer
Vasista, A. , Stockler, M. , Martin, A. , Pavlakis, N. , Sjoquist, K. , Goldstein, D. , Gill, S. , Jain, V. , Liu, G. , Kannourakis, G. , Kim, Y. H., Nott, L. , Snow, S. , Burge, M. , Harris, D. , Jonker, D. , Chua, Y. J., Epstein, R. , Bonaventura, A. and Kiely, B
(2019), ONCOLOGIST, 24(11), e1102-7
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Tie J, Cohen JD, Wang Y, Li L, Christie M, Simons K, Elsaleh H, Kosmider S, Wong R, Yip D, Lee M, Tran B, Rangiah D, Burge M, Goldstein D, Singh M, Skinner I, Faragher I, Croxford M, Bampton C, Haydon A, Jones IT, S Karapetis C, Price T, Schaefer MJ, Ptak J, Dobbyn L, Silliman N, Kinde I, Tomasetti C, Papadopoulos N, Kinzler K, Volgestein B, Gibbs P
(2019), Gut, 68(4), 663-71
Towards a strategy for clinical quality registries in Australia
Ahern S, Evans S, Hopper I, Zalcberg J
(2019), Aust Health Rev, 43(3), 284-7
DOI: 10.1071/AH17201
Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype
Jayasekara, H., English, D.R., Haydon, A., Hodge, A.M., Lynch, B.M., Rosty, C., Williamson, E.J., Clendenning, M., Southey, M.C., Jenkins, M.A., Room, R., Hopper, J.L., Milne, R.L., Buchanan, D.D., Giles, G.G., MacInnis, R.J.
(2018), Int J Cancer, 238-250
DOI: 10.1002/ijc.31049
The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial
Davis SR, Robinson PJ, Jane F, White S, Brown KA, Piessens S, Edwards A, McNeilage J, Woinarski J, Chipman M, Bell RJ
(2018), Clin Endocrinol, 89(5), 605-612
DOI: 10.1111/cen.13830
Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma
Lewin J, Sayers L, Kee D, Walpole I, Sanelli A, Te Marvelde L, Herschtal A, Spillane J, Gyorki D, Speakman D, Estall V, Donahoe S, Pohl M, Pope K, Chua M, Sandhu S, McArthur GA, McCormack CJ, Henderson M, Hicks RJ, Shackleton M
(2018), Ann Oncol, 29(7), 1569-1574
Immunotherapy induced pyrexia and the role of PET/CT
McLean L, Soon JA, Haydon A
(2018), Int J Case Rep, 2, 29
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Lichinitser M, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Maio M, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan P, Ibrahim N, Marreaud S, van Akkooi ACJ, Suciu S, Robert C
(2018), N Engl J Med, 378(19), 1789-1801
Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy
Adler NR, Wolfe R, McArthur GA, Kelly JW, Haydon A, McLean CA, Mar VJ
(2018), Br J Cancer, 118(10), 1289-1295
Concordance of somatic mutational profile in multiple primary melanomas
Adler NR, McLean CA, Wolfe R, Kelly JW, McArthur GA, Haydon A, Tra T, Cummings N, Mar VJ
(2018), Pigment Cell Melanoma Res, 31(5), 592-603
DOI: 10.1111/pcmr.12702
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
Iveson TJ, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Scudder C, Boyd KA, Briggs A, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Harrison M, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan HS, Paul J
(2018), Lancet Oncol, 19(4), 562-578
Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres
Grant M, Haydon A, Au L, Wilkins S, Oliva K, Segelov E, Antill Y, Carne P, Ranchod P, Polglase A, Farmer C, Chin M, Wale R, Simpson P, Bell S, Skinner S, McMurrick P, Shapiro J
(2018), Int J Surg, 51, 71-75
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors
Ameratunga M, Ch»nard-Poirier M, Moreno Candilejo I, Pedregal M, Lui A, Dolling D, Aversa C, Ingles Garces A, Ang JE, Banerji U, Kaye S, Gan H, Doger B, Moreno V, de Bono J, Lopez J
(2018), Eur J Cancer, 89, 56-63
Anti-angiogenic therapy for high-grade glioma
Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M
(2018), Cochrane Database Syst Rev, 11, CD008218
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit
Sundar R, Custodio A, Petruckevich A, Ch»nard-Poirier M, Ameratunga M, Collins D, Lim J, Kaye SB, Tunariu N, Banerji U, de Bono J, Lopez J
(2018), Clin Oncol, 30(3), 185-191
Personalized cancer immunotherapy: Today's challenge and tomorrow's promise
Ameratunga M, Xu W, Lopez J
(2018), J Immunother Precis Oncol, 1, 56-67
CNS cancer immunity cycle and strategies to target this for glioblastoma
Ameratunga M, Coleman N, Welsh L, Saran F, Lopez J
(2018), Oncotarget, 9(32), 22802-22816
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials
Sundar R, McVeigh T, Dolling D, Petruckevitch A, Diamantis N, Ang JE, Chenard-Poiri»r M, Collins D, Lim J, Ameratunga M, Khan K, Kaye SB, Banerji U, Lopez J, George AJ, de Bono JS, van der Graaf WT
(2018), Eur J Cancer, 101, 55-61
A single-institution prospective evaluation of a neuro-oncology multidisciplinary team meeting
Ameratunga M, Miller D, Ng W, Wada M, Gonzalvo A, Cher L, Gan HK
(2018), J Clin Neurosci, 56, 127-130